232
J Incl Phenom Macrocycl Chem (2013) 75:223–233
complexation with tauro- and glyco-conjugated bile salts. Lang-
muir 27, 5832–5841 (2011)
References
22. Chen, W., Chang, C.-E., Gilson, M.K.: Calculation of cyclo-
dextrin binding affinities: energy, entropy, and implication for
drug design. Biophys. J. 87, 3035–3049 (2004)
23. Chang, C.E., Gilson, M.K.: Free energy, entropy, and induced fit
in host-guest recognition: calculations with the second-generation
mining minima algorithm. J. Am. Chem. Soc. 126, 13156–13164
(2004)
1. Szejtli, J.: Cyclodextrin Technology. Kluwer, Dordrecht (1988)
2. Loftsson, T., Brewster, M.E., Masson, M.: Role of cyclodextrins
in improving oral drug delivery. Am. J. Drug Deliv. 2, 175–261
(2004)
3. Carrier, R.L., Miller, L.A., Ahmed, I.: The utility of cyclodextrins
for enhancing oral bioavailability. J. Control. Release. 123, 78–99
(2007)
4. Davis, M.E., Brewster, M.E.: Cyclodextrin-based pharmaceutics:
past, present and future. Nat. Rev. Drug. Discov. 3, 1023–1035
(2004)
5. Brewster, M.E., Loftsson, T.: Cyclodextrins as pharmaceutical
solubilizers. Adv. Drug. Deliv. Rev. 59, 645–666 (2007)
6. Rajewski, R.A., Stella, V.J.: Pharmaceutical applications of
cyclodextrins. 2. in vivo drug delivery. J. Pharm. Sci. 85,
1142–1169 (1996)
7. Thompson, D.O.: Cyclodextrins-enabling excipients: their pres-
ent and future use in pharmaceuticals. Crit. Rev. Ther. Drug.
Carrier. Syst. 14, 1–104 (1997)
8. Uekama, K.: Design and evaluation of cyclodextrin-based drug
formulation. Chem. Pharm. Bull. 52, 900–915 (2004)
9. Westerberg, G., Wiklund, L.: b-cyclodextrin reduces bioavail-
ability of orally administered [3H]benzo[a]pyrene in the rat.
J. Pharm. Sci. 94, 114–119 (2005)
10. Uekama, K., Hirayama, F., Irie, T.: Cyclodextrin drug carrier
systems. Chem. Rev. 98, 2045–2076 (1998)
11. Ono, N., Hirayama, F., Arima, H., Uekama, K., Rytting, J.H.:
Model analysis for oral absorption of a drug/cyclodextrin com-
plex involving competitive inclusion complexes. J. Incl. Phenom.
Macrocycl. Chem. 44, 06–93 (2003)
24. Molecular Operating Environment (MOE), Version 2006.08
[Computer Program]. Montreal (2002)
25. Holm, R., Shi, W., Hartvig, R.A., Askjær, S., Madsen, J.C.,
Westh, P.: Thermodynamics and structure of inclusion com-
pounds of tauro- and glyco-conjugated bile salts and b-cyclo-
dextrins. Phys. Chem. Chem. Phys. 11, 5070–5078 (2009)
26. Chang, C.E., Chen, W., Gilson, M.K.: Ligand configurational
entropy and protein binding. Proc. Natl Acad. Sci. USA 104,
1534–1539 (2007)
27. Halgren, T.A.: Merck molecular force field. 1. Basis, form, scope,
parameterization, and performance of MMFF94. J. Comput.
Chem. 17, 490–519 (1996)
28. Halgren, T.A.: Merck molecular force field. 2. MMFF94 van der
waals and electrostatic parameters for intermolecular interactions.
J. Comput. Chem. 17, 520–552 (1996)
29. Halgren, T.A.: Merck molecular force field. 3. Molecular
geometries and vibrational frequencies for MMFF94. J. Comput.
Chem. 17, 553–586 (1996)
30. Halgren, T.A., Nachbar, R.B.: Merck molecular force field. 4.
Conformational energies and geometries for MMFF94. J. Com-
put. Chem. 17, 587–615 (1996)
31. Halgren, T.A.: Merck molecular force field. 5. Extension of
MMFF94 using experimental data, additional computational data,
and empirical rules. J. Comput. Chem. 17, 616–641 (1996)
32. Halgren, T.A.: MMFF VI. MMFF94s option for energy mini-
mization studies. J. Comput. Chem. 20, 720–729 (1999)
33. Halgren, T.A.: MMFF VII. Characterization of MMFF94,
MMFF94s, and other widely available force fields for confor-
mational energies and for intermolecular-interaction energies and
geometries. J. Comput. Chem. 20, 730–748 (1999)
34. Hofmann, A.F., Roda, A.: Physicochemical properties of bile
acids and their relationship to biological properties: an overview
of the problem. J. Lipid Res. 25, 1477–1489 (1984)
35. Roda, A., Hofmann, A.F., Mysels, K.J.: The influence of bile salt
structure on self-association in aqueous solutions. J. Biol. Chem.
258, 6362–6370 (1983)
36. Jana, P.K., Moulik, S.P.: Interaction of bile salts with hex-
adecyltrimethylammonium bromide and sodium dodecyl sulfate.
J. Phys. Chem. 95, 9525–9532 (1991)
37. Funasaki, N., Ueshiba, R., Hada, S., Neya, S.: Stepwise self-asso-
ciation of sodium taurocholate and taurodeoxycholate as revealed
by chromatography. J. Phys. Chem. 98, 11541–11548 (1994)
38. Garidel, P., Hildebrand, A., Neubert, R., Blume, A.: Thermody-
namic characterization of bile salt aggregation as a function of
temperature and ionic strength using isothermal titration calo-
rimetry. Langmuir 16, 5267–5275 (2000)
12. Marshall, J.J.M.: Kinetic difference between hydrolyses of c-
cyclodextrin by human salivary and pancreatic a-amylase. BBA
661, 142–147 (1981)
13. Kondo, H., Nakatani, H., Hiromi, K.: In vitro action of human
and porcine a-amylase on cyclo-malto-oligosaccharides. Carbo-
hydr. Res. 204, 207–213 (1990)
14. Lipindski, C.A.: Drug-like properties and the causes of poorly
solubility and poor permeability. J. Pharmacol. Toxicol. Methods
44, 235–249 (2000)
15. Cabrer, P.R., Alvarez-Parrilla, E., Al-Soufi, W., Meijide, F.,
´
Nun˜ez, E.R., Tato, J.V.: Complexation of bile salts by natural
cyclodextrins. Supramol. Chem. 15, 33–43 (2003)
16. Tan, Z.J., Zhu, X.X., Brown, G.R.: Formation of inclusion
complexes of cyclodextrins with bile salt anions as determined by
NMR titration studies. Langmuir 10, 1034–1039 (1994)
17. Holm, R., Hartvig, R.A., Nicolajsen, H.V., Westh, P., Østergaard,
J.: Characterization of the complexation of tauro- and glyco-
conjugated bile salts with c-cyclodextrin and 2-hydroxypropyl-c-
cyclodextrin using affinity capillary electrophoresis. J. Incl.
Phenom. Macrocycl. Chem. 61, 161–169 (2008)
18. Cooper, A., Nutley, M.A., Camilleri, P.: Microcalometry of chiral
surfactant–cyclodextrin interactions. Anal. Chem. 70, 5024–5028
(1998)
19. Abadie, C., Hug, M., Ku¨bli, C., Gains, N.: Effect of cyclodextrins
and undigested starch on the loss of chenodeoxycholate in the
feces. Biochem. J. 229, 725–730 (1994)
20. Alvaro, D., Cantatore, A., Attili, A.F., Gianni Corrandini, S., De
Luca, C., Minervini, G., Di Blase, A., Angelico, M.: Relation-
ships between bile salts hydrophilicity and phosphorlipid com-
position in bile of various animal species. Comp. Biochem.
Physiol. 83B, 551–554 (1986)
21. Schonbeck, C., Westh, P., Madsen, J.C., Larsen, K.L., Stade,
L.W., Holm, R.: Methylated beta-cyclodextrins: influence of
degree and pattern of substitution on the thermodynamics of
39. Schneider, H.-J., Hacket, F., Ru¨diger, V.: NMR studies of
cyclodextrins and cyclodextrin complexes. Chem. Rev. 98,
1755–1785 (1998)
¨
40. Holm, R., Madsen, J.C., Shi, W., Larsen, K.L., Stade, L.W.,
Westh, P.: Thermodynamics of complexation of tauro- and glyco-
conjugated bile salts with two modified b-cyclodextrins. J. Incl.
Phenom. Macrocycl. Chem. 69, 201–211 (2011)
41. Mucci, A., Schenetti, L., Vandelli, M.A., Ruozi, B., Salvioli, G.,
Forni, F.: Comparison between Roesy and 13C NMR complexa-
tion shifts in deriving the geometry of inclusion compounds: a
123